Education
About Us
Working with TipRanks
Follow Us
Human Metabolome Technologies, Inc. (JP:6090)
:6090
Total Valuation
Human Metabolome Technologies, Inc. has a market cap or net worth of ¥4.07B. The enterprise value is ¥3.08B.
Market Cap¥4.07B
Enterprise Value¥3.08B
Share Statistics
Human Metabolome Technologies, Inc. has 5,919,797 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,919,797
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Human Metabolome Technologies, Inc.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 11.66%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)11.66%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee25.09M
Profits Per Employee4.41M
Employee Count58
Asset Turnover0.61
Inventory Turnover10.45
Valuation Ratios
The current PE Ratio of Human Metabolome Technologies, Inc. is 21.4. Human Metabolome Technologies, Inc.’s PEG ratio is 2.95.
PE Ratio21.4
PS Ratio3.09
PB Ratio2.36
Price to Fair Value2.36
Price to FCF19.99
Price to Operating Cash Flow0.00
PEG Ratio2.95
Income Statement
In the last 12 months, Human Metabolome Technologies, Inc. had revenue of 1.46B and earned 256.00M in profits. Earnings per share was 43.59.
Revenue1.46B
Gross Profit922.00M
Operating Income249.00M
Pretax Income269.00M
Net Income256.00M
EBITDA353.00M
Earnings Per Share (EPS)43.59
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Human Metabolome Technologies, Inc. pays an annual dividend of ¥15, resulting in a dividend yield of 2.35%
Dividend Per Share¥15
Dividend Yield2.35%
Payout Ratio46.07%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change13.28%
50-Day Moving Average664.94
200-Day Moving Average716.12
Relative Strength Index (RSI)69.75
Average Volume (3m)10.25K
Important Dates
Human Metabolome Technologies, Inc. upcoming earnings date is Feb 18, 2026, TBA (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateFeb 18, 2026
Ex-Dividend Date―
Financial Position
Human Metabolome Technologies, Inc. as a current ratio of 4.15, with Debt / Equity ratio of 5.77%
Current Ratio4.15
Quick Ratio4.04
Debt to Market Cap0.02
Net Debt to EBITDA-4.11
Interest Coverage Ratio99.88
Taxes
In the past 12 months, Human Metabolome Technologies, Inc. has paid 13.00M in taxes.
Income Tax13.00M
Effective Tax Rate0.05
Enterprise Valuation
Human Metabolome Technologies, Inc. EV to EBITDA ratio is 8.63, with an EV/FCF ratio of 13.54.
EV to Sales2.09
EV to EBITDA8.63
EV to Free Cash Flow13.54
EV to Operating Cash Flow8.17
Balance Sheet
Human Metabolome Technologies, Inc. has ¥1.56B in cash and marketable securities with ¥110.00M in debt, giving a net cash position of ¥1.45B billion.
Cash & Marketable Securities¥1.56B
Total Debt¥110.00M
Net Cash¥1.45B
Net Cash Per Share¥245.28
Tangible Book Value Per Share¥322.70
Margins
Gross margin is 63.34%, with operating margin of 17.11%, and net profit margin of 17.59%.
Gross Margin63.34%
Operating Margin17.11%
Pretax Margin18.49%
Net Profit Margin17.59%
EBITDA Margin24.26%
EBIT Margin17.18%
Analyst Forecast
The average price target for Human Metabolome Technologies, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.82%
EPS Growth Forecast-21.75%